Stock Scorecard



Stock Summary for Tactile Systems Technology Inc (TCMD) - $29.13 as of 12/19/2025 6:52:18 PM EST

Total Score

15 out of 30

Safety Score

41 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for TCMD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TCMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TCMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for TCMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for TCMD (41 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 4
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for TCMD

Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 28% 12/18/2025 11:09:00 AM
Tactile Systems Technology (NASDAQ:TCMD) Hits New 52-Week High - Still a Buy? 12/9/2025 5:09:00 PM
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Given Average Rating of "Moderate Buy" by Brokerages 12/9/2025 6:09:00 AM
Are Medical Stocks Lagging Tactile Systems Technology (TCMD) This Year? 12/1/2025 4:53:00 AM
Tactile Systems Technology (TCMD) is a Great Momentum Stock: Should You Buy? 11/28/2025 6:09:00 PM
Tactile Systems Technology Repeat Insider Selling Not A Positive Indicator 11/24/2025 5:09:00 PM
Tactile Systems Technology Repeat Insider Selling Not A Positive Indicator 11/24/2025 1:12:00 PM
Zacks.com featured highlights include Tactile Systems, Canadian Natural Resources, Arlo and Celestica 11/20/2025 4:53:00 AM
Tactile Systems Technology (TCMD) Price Target Increased by 42.57% to 24.48 11/19/2025 7:08:00 PM
Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference 11/18/2025 4:05:00 PM

Financial Details for TCMD

Company Overview

Ticker TCMD
Company Name Tactile Systems Technology Inc
Country USA
Description Tactile Systems Technology, Inc. (Ticker: TCMD) is a leading medical technology firm headquartered in Minneapolis, Minnesota, dedicated to the development of innovative therapeutic devices aimed at managing chronic conditions such as lymphedema and venous insufficiency. The company focuses on enhancing patient outcomes through its proprietary, cutting-edge solutions, which significantly improve the quality of life for those affected by these conditions. Tactile’s strategic emphasis on expanding its product portfolio and strengthening its market presence underscores its potential for growth, making it an attractive investment opportunity for institutional investors seeking to capitalize on advancements in the healthcare sector.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 29.13
Price 4 Years Ago 19.03
Last Day Price Updated 12/19/2025 6:52:18 PM EST
Last Day Volume 422,915
Average Daily Volume 476,996
52-Week High 29.71
52-Week Low 8.61
Last Price to 52 Week Low 238.33%

Valuation Measures

Trailing PE 38.92
Industry PE 27.43
Sector PE 126.11
5-Year Average PE 2.57
Free Cash Flow Ratio 9.87
Industry Free Cash Flow Ratio 22.63
Sector Free Cash Flow Ratio 26.50
Current Ratio Most Recent Quarter 3.61
Total Cash Per Share 2.95
Book Value Per Share Most Recent Quarter 9.18
Price to Book Ratio 3.22
Industry Price to Book Ratio 4.02
Sector Price to Book Ratio 26.03
Price to Sales Ratio Twelve Trailing Months 2.12
Industry Price to Sales Ratio Twelve Trailing Months 3.98
Sector Price to Sales Ratio Twelve Trailing Months 19.08
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 22,335,600
Market Capitalization 650,636,028
Institutional Ownership 98.75%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 71.40%
Annual Earnings Growth -40.52%
Reported EPS 12 Trailing Months 0.76
Reported EPS Past Year 0.37
Reported EPS Prior Year 0.71
Net Income Twelve Trailing Months 18,168,000
Net Income Past Year 16,960,000
Net Income Prior Year 28,515,000
Quarterly Revenue Growth YOY 17.30%
5-Year Revenue Growth 9.11%
Operating Margin Twelve Trailing Months 12.80%

Balance Sheet

Total Cash Most Recent Quarter 65,965,000
Total Cash Past Year 94,367,000
Total Cash Prior Year 61,033,000
Net Cash Position Most Recent Quarter 44,222,000
Net Cash Position Past Year 71,147,000
Long Term Debt Past Year 23,220,000
Long Term Debt Prior Year 26,176,000
Total Debt Most Recent Quarter 21,743,000
Equity to Debt Ratio Past Year 0.90
Equity to Debt Ratio Most Recent Quarter 0.90
Total Stockholder Equity Past Year 216,597,000
Total Stockholder Equity Prior Year 193,642,000
Total Stockholder Equity Most Recent Quarter 204,949,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 39,458,000
Free Cash Flow Per Share Twelve Trailing Months 1.77
Free Cash Flow Past Year 38,146,000
Free Cash Flow Prior Year 33,374,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 1.97
MACD Signal 2.04
20-Day Bollinger Lower Band 5.98
20-Day Bollinger Middle Band 18.26
20-Day Bollinger Upper Band 30.54
Beta 0.93
RSI 77.24
50-Day SMA 14.77
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 12/18/2025 9:25:27 AM EST